RA
Rahul Abraham Mamman
About Rahul Abraham Mamman
Data last updated:
Rahul Abraham Mamman is a Director at M.P.C. Pharma Private Limited (since 2011), Director at Newmalayalam Steel Limited (since 2023) and Managing Director at Greenspecialities Private Limited (since 2019), and holds 16 more current directorships. The companies operate in Pharma, Manufacturing and Healthcare. The 15 current companies with reported revenue have a combined latest revenue of ₹1,174 Cr; the largest is M.P.C. Pharma Private Limited at ₹455 Cr (FY 2024). Earlier, Rahul Abraham Mamman was a Director at Angamaly Drug Distributors Private Limited (2021–2022) and Managing Director at Bio Pharma Cochin Private Limited (2019–2026) and 2 more.
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 M.P.C. Pharma Private Limited U51102TN2011PTC078857 | Director | 17 Jan 2011 | 2011 | ₹455 Cr (FY 2024) | Active |
 Newmalayalam Steel Limited L27209KL2017PLC048762 | Director | 15 Dec 2023 | 2017 | ₹360 Cr (FY 2023) | Active |
| Greenspecialities Private Limited U24230KL2019PTC058138 | Managing Director | 24 May 2019 | 2019 | ₹112 Cr (FY 2024) | Active |
| Anandha Pharmacy Private Limited U24304KL2019PTC058579 | Managing Director | 26 Jun 2019 | 2019 | ₹73.51 Cr (FY 2025) | Active |
 Thodupuzha Drug House Private Limited U51909KL2018PTC052924 | Director | 16 Apr 2018 | 2018 | ₹56.76 Cr (FY 2024) | Active |
 Medigenmed Care Private Limited U24230KL2019PTC058402 | Managing Director | 13 Jun 2019 | 2019 | ₹55.71 Cr (FY 2024) | Active |
| Haeal Enterprises Private Limited U24299KL2020PTC066280 | Managing Director | 09 Dec 2020 | 2020 | ₹30.49 Cr (FY 2025) | Active |
| Biorex Super Speciality Private Limited U51397KL2022PTC076090 | Managing Director | 09 Apr 2024 | 2022 | ₹20.16 Cr (FY 2025) | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Angamaly Drug Distributors Private Limited U24299KL2021PTC072656 | Director | 30 Nov 2021 | 2021 | ₹29.27 Cr (FY 2024) | Active |
| Bio Pharma Cochin Private Limited U36900KL2019PTC056737 | Managing Director | 12 Feb 2019 | 2019 | ₹23.84 Cr (FY 2022) | Active |
| Unbottle Private Limited U51909KA2022PTC159630 | Director | 01 Apr 2022 | 2022 | ₹1.00 Cr (FY 2024) | Active |
| Thodupuzha Medigen Private Limited U51909KL2018PTC054346 | Director | 16 Aug 2018 | 2018 | ₹1.9 Lakh (FY 2025) | Active |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Rahul Abraham Mamman
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Rahul Abraham Mamman
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Rahul Abraham Mamman
Rahul Abraham Mamman currently holds 19 directorships: M.P.C. Pharma Private Limited (Director, since 17 Jan 2011, revenue ₹455 Cr (FY 2024)); Newmalayalam Steel Limited (Director, since 15 Dec 2023, revenue ₹360 Cr (FY 2023)); Greenspecialities Private Limited (Managing Director, since 24 May 2019, revenue ₹112 Cr (FY 2024)); Anandha Pharmacy Private Limited (Managing Director, since 26 Jun 2019, revenue ₹73.51 Cr (FY 2025)); Thodupuzha Drug House Private Limited (Director, since 16 Apr 2018, revenue ₹56.76 Cr (FY 2024)); and 14 more.
Rahul Abraham Mamman was first appointed on 17 Jan 2011 as Director at M.P.C. Pharma Private Limited. The most recent appointment on record is 14 May 2026 at Tsr Us Pharma Private Limited.
The 15 current companies of Rahul Abraham Mamman that report revenue have a combined latest revenue of ₹1,174 Cr: M.P.C. Pharma Private Limited ₹455 Cr (FY 2024); Newmalayalam Steel Limited ₹360 Cr (FY 2023); Greenspecialities Private Limited ₹112 Cr (FY 2024); Anandha Pharmacy Private Limited ₹73.51 Cr (FY 2025); Thodupuzha Drug House Private Limited ₹56.76 Cr (FY 2024); and 10 more.
Rahul Abraham Mamman held 4 earlier board appointments: Angamaly Drug Distributors Private Limited (Director, 30 Nov 2021 to 25 Mar 2022); Bio Pharma Cochin Private Limited (Managing Director, 12 Feb 2019 to 28 Feb 2026); Unbottle Private Limited (Director, 01 Apr 2022 to 14 Apr 2023); Thodupuzha Medigen Private Limited (Director, 16 Aug 2018 to 14 Feb 2026).
The current boards of Rahul Abraham Mamman's companies include Mamman Abraham (M.P.C. Pharma Private Limited), Avinash Panangatt Venugopal (Newmalayalam Steel Limited), Darsana D Prabhu (Newmalayalam Steel Limited), Divyakumar Jain (Newmalayalam Steel Limited), Jijo Maliyakkal (Newmalayalam Steel Limited), Mahendra Kumar Jain (Newmalayalam Steel Limited), among others.